Search PubMed⌕ Search

Biomedical subjects

A Bitoun

Publications and source records attributed to A Bitoun.

53 records · Page 3Linked to original sources
PubMed1977

[Total parenteral nutrition in the adult. Theoretical aspects (author's transl)].

When oral or enteral feeding becomes impossible or inadequate, total parenteral nutrition makes it possible to reduce the occurrence of malnutrition states as complications of medicosurgical disorders. From a practical point of view it should provide a minimum fluid intake of 30 ml/kg with a nitrogen intake of the order of 150 to 300 mg/kg/day with sufficient quantities of all essential amino acids in a balanced ration. In most instances the calorie intake should be 40 to 60 Kcal/kg/day. Non-protein calories are obtained from carbohydrates or fats but the ideal percentage of each of these two nutrients is not known. In order to be effective and well tolerated, intravenous nutrition of this sort must be adapted to each patient and should be administered by a qualified medical and nursing team in order to minimise the metabolic and septic risks secondary to the techniques used.

Amino Acids↗
PubMedDate not supplied

[Inverse polypoid hamartoma of the rectum with colonic extension of the lesions and deep cystic colitis with rectal involvement. Apropos of an anatomo-clinical case report].

The authors report the case of a 38 year old man, presenting with an inverted polypoid hamartoma (IPH) of the rectum, associated with similar colonic localizations and they show the resemblance of these lesions to the colitis cystica profunda (CCP) with involvement of the entire large bowel and eventually the rectum. In fact, moreover, the symptoms, the digital rectal examination and the endoscopic, radiological and pathological data are similar but, in the reported cases, the IPH always included at least one rectal localization whereas the CCP might not show rectal lesion. Advanced lesions of rectal IPH may be confused, by endoscopy and pathology with adenomas or adenocarcinomas. Consequently it is essential to perform large and deep biopsies for histological diagnosis. The IPH and the CCP are benign diseases but "recurrence" may be observed in case of incomplete removal. The removal has to be adequate but not mutilating, either by surgery or by laser endoscopic photoablation. The choice of the procedure will depend upon the size of the lesion.

Adult↗
PubMedDate not supplied

[Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn's disease: a prospective multicenter controlled trial in 155 patients].

The prevention of relapse in quiescent Crohn's disease remains a major therapeutic challenge. The present study is a double blind placebo (P)-controlled, randomized, multicentre cooperative trial designed to test the effectiveness of levamisole (L) in the prophylaxis against flare up in patients with quiescent Crohn's disease. The trial included 2 successive phases: a) phase I:167 patients with inactive disease (but who had not had previous resection of all diseased tissue) were randomly and double blindly assigned to receive either L (150 mg orally once weekly) or P; patients were randomized in 2 strata: those having experienced a recent flare up (within the 3 months preceding their entry into the trial: red strata) versus others (blue strata). Patients were followed up at 3 monthly intervals during 2 years. Initially there was no significant difference between L and P groups as regard to age, sex ratio, duration of disease at the time of randomization, incidence of prior intestinal resection, Crohn's disease topography, clinical activity; biological activity was slightly but significantly higher (P less than 0.05) in the P group. Twelve patients were withdrawn from analysis (lost to follow-up: 2; inadequate respect of the protocol: 10), leaving 155 patients (78 L, 77 P) who completed the study. L did not significantly influence any of the following parameters: incidence of attacks (L: 37 p. 100; P: 35 p. 100), lag time between the entry into the trial and the occurrence of the attack (L: 32.7 +/- 5.2; P: 41.8 +/- 5.8; m +/- SEM; weeks), curves of maintenance in remission (Kaplan-Meier method), outcome rank, severity of attacks. Attempts to analyse separately certain subgroups--subjects with purely colonic (+/- anal) disease, subjects with small bowel localization (+/- anus), patients of the red or blue strata--did not show any statistical difference between L and P. Thirteen patients left the trial for minor intolerance (10 L, 3 P). b) Phase II lasted one further year and involved the patients still in remission and in the trial at the end of phase I (n = 57). Those who had received L during phase I were randomized between continuance of L (L leads to L) vs. a change to P (L leads to P); those who had been on P during phase I were randomized between continuance of P vs. a switch to L.(ABSTRACT TRUNCATED AT 400 WORDS)

Clinical Trials as Topic↗